SCHEMBL19890899

SCHEMBL19890899

CCCCCCCCCCCCCCCCc1nc(N2CC(Oc3c(CCCCCCCCCCCCCCCC)nc(N4CCCC4)nc3OC3CCC3)C2)nc(OC2CCC2)c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18005522 0.92 MEN1 (0.32) —
SCHEMBL18005212 0.91 SMN1; SMN2 (0.32) —
SCHEMBL19900340 0.90 CHRM1 (0.30) —
SCHEMBL18005537 0.79 MEN1 (0.32) —
SCHEMBL19900683 0.77 CHRM1 (0.30) —
SCHEMBL18005617 0.77 CHRM1 (0.30) —
SCHEMBL21202588 0.76 MAPT (0.36) —
SCHEMBL24330463 0.76 KCNQ3 (0.30) —
SCHEMBL19900152 0.75 NAAA (0.33) —
SCHEMBL18005415 0.75 KCNQ3 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016133959-A9 THERAPEUTIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-02-22 — — WO disclosed
Send feedback